Blockchain Registration Transaction Record

Brain Tumors in Kids Spread via Immune Cell Scaffolding

Scientists discover that microglia produce fibronectin, enabling aggressive pediatric brain tumors to spread. CNS Pharmaceuticals conducts research on treatments.

This discovery is crucial because diffuse midline gliomas are among the deadliest pediatric brain tumors, with a median survival of less than one year. By revealing that microglia produce fibronectin to facilitate tumor spread, researchers have identified a potential new drug target. For families affected by these tumors, this research offers hope for more effective treatments that could slow or halt disease progression. Additionally, companies like CNS Pharmaceuticals are working on therapies that could one day incorporate these findings, potentially improving outcomes for children diagnosed with this devastating condition.